William Blair stays Outperform on Ionis Pharmaceuticals (IONS); pricing update 'positive'
William Blair analyst Myles Minter reiterated an Outperform rating on Ionis Pharmaceuticals (NASDAQ: IONS)The analyst commented, "We view today’s pricing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
